GRYSKA DAVID W

CIK 000120233512 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001202335

Recent Transactions

50 trades

Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2026-06-11+19,188→ 19,188 total
Award
Definium Therapeutics, Inc.$DFTX
Common Shares
2026-06-11+4,666→ 19,900 total
Award
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2026-05-29+18,353→ 18,353 total
Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2025-06-12+75,187→ 75,187 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2025-03-20+31,000→ 31,000 total
Purchase
Definium Therapeutics, Inc.$DFTX
Common Shares
2024-12-05$7.17/sh+2,500→ 19,851 total
Purchase
Definium Therapeutics, Inc.$DFTX
Common Shares
2024-08-23$5.98/sh+3,500→ 17,351 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2024-08-20+50,000→ 50,000 total
Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2024-06-10+16,506→ 16,506 total
Disposition to Issuer
Seagen Inc.
Restricted Stock Units
2023-12-14−2,044→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−3,676→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−9,260→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−9,260→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−9,260→ 0 total
Disposition to Issuer
Seagen Inc.
Common Stock
2023-12-14$229.00/sh−49,003→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−9,260→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−3,462→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−8,750→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−7,038→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−3,171→ 0 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2023-09-19+25,000→ 25,000 total
Award
Forte Biosciences, Inc.$FBRX
Common Stock
2023-07-31$1.01/sh+148,514→ 148,514 total
Award
Definium Therapeutics, Inc.$DFTX
Director's Deferred Share Units
2023-06-21+13,131→ 13,131 total
Award
Definium Therapeutics, Inc.$DFTX
Stock Option (Right to Buy)
2023-06-21+37,594→ 37,594 total
Award
Definium Therapeutics, Inc.$DFTX
Common Shares
2023-06-21+13,851→ 13,851 total
Award
Seagen Inc.
Common Stock
2023-05-31+2,044→ 51,047 total
Exercise/Conversion
Seagen Inc.
Common Stock
2023-02-13$36.70/sh+8,750→ 49,003 total
Exercise/Conversion
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2023-02-13−8,750→ 0 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2023-01-10+50,000→ 50,000 total
Disposition to Issuer
AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
2022-11-21$9.14/sh−16,854→ 0 total
Disposition to Issuer
AERIE PHARMACEUTICALS INC
Common Stock
2022-11-21$15.25/sh−11,495→ 0 total
Disposition to Issuer
AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
2022-11-21$1.98/sh−7,800→ 0 total
Disposition to Issuer
AERIE PHARMACEUTICALS INC
Common Stock
2022-11-21$15.25/sh−1,996→ 0 total
Sale
Seagen Inc.
Common Stock
2022-11-11$129.10/sh−7,500→ 40,253 total
Award
AERIE PHARMACEUTICALS INC
Stock Option (right to buy)
2022-06-09+16,854→ 16,854 total
Award
AERIE PHARMACEUTICALS INC
Common Stock
2022-06-09+6,245→ 11,495 total
Award
Seagen Inc.
Common Stock
2022-05-13+1,503→ 47,753 total
Award
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2022-05-13+3,676→ 3,676 total
Exercise/Conversion
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2022-04-19−690→ 0 total
Exercise/Conversion
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2022-04-19−1,516→ 690 total
Exercise/Conversion
Seagen Inc.
Common Stock
2022-04-19$20.06/sh+690→ 46,940 total
Sale
Seagen Inc.
Common Stock
2022-04-19$143.32/sh−1,794→ 46,250 total
Sale
Seagen Inc.
Common Stock
2022-04-19$145.08/sh−690→ 46,250 total
Exercise/Conversion
Seagen Inc.
Common Stock
2022-04-19$20.06/sh+1,516→ 47,766 total
Sale
Seagen Inc.
Common Stock
2022-04-19$144.17/sh−1,516→ 46,250 total
Exercise/Conversion
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2022-04-19−1,794→ 2,206 total
Exercise/Conversion
Seagen Inc.
Common Stock
2022-04-19$20.06/sh+1,794→ 48,044 total
Exercise/Conversion
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2022-02-07−1,029→ 6,371 total
Exercise/Conversion
Seagen Inc.
Common Stock
2022-02-07$20.06/sh+1,100→ 47,350 total
Sale
Seagen Inc.
Common Stock
2022-02-07$137.45/sh−1,100→ 46,250 total

GRYSKA DAVID W

Recent Transactions

Companies

Recent Filings

Address